Salix Pharmaceuticals, Ltd. (SLXP) Announces Pricing of a Public Offering of Common Stock
11/18/2009 8:50:37 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Reports 3Q2009 Results
11/10/2009 10:03:45 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) to Host Analyst Day on November 18
11/4/2009 9:32:27 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Secures Additional Intellecutual Property Relating to Rifaximin
11/3/2009 9:42:53 AM
More...
|
FDA Approves New Salix Pharmaceuticals, Ltd. (SLXP) Product Exclusively in Catalent Pharma Solutions's Zydis(R) Fast Dissolve Technology
11/3/2009 9:42:14 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Reviews American Association for the Study of Liver Diseases Annual Meeting
11/2/2009 9:09:19 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Announces 3Q2009 Financial Results Conference Call and Webcast
10/26/2009 9:26:35 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Acquires U.S. Right to Lupin Ltd. (LUPN.BO)'s Proprietary Bioadhesive Technology for Extended Release Rifaximin Product
10/5/2009 6:31:03 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) to Present at JMP Securities Conference
9/28/2009 11:38:37 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP)'s Bowel Drug Meets Late-Stage Goals
9/14/2009 6:45:16 AM
More...
|
|